Bausch Health Companies Inc 2024年度报告

SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_____________________________ FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year EndedDecember 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Bausch Health Companies Inc.(Exact Name of Registrant as Specified in its Charter) British Columbia,Canada98-0448205(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8(Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code(514) 744-6792 Securities registered pursuant to Section 12(b) of the Act: (Title of class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of theSecurities Act. Yes ýNo o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act. Yes oNo ý Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 orSection 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorterperiodthat the registrant was required to file such reports),and(2) has been subject to such filingrequirements for the past 90 days. Yes ýNo o Indicate by check mark whether the registrant has submitted electronically every Interactive Data Filerequired to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for suchshorter period that the registrant was required to submit such files). Yes ýNo o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “largeacceleratedfiler,”“accelerated filer,”“smaller reporting company,”and“emerging growth company”inRule 12b-2 of the Exchange Act. Large acceleratedfilerxAccelerated filerNon-accelerated filer(Do not check if asmallerreporting company)SmallerreportingcompanyEmerginggrowth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant toSection 13(a) of the Exchange Act. Indicate by check mark whether the registrant has filed a report on and attestation to its management’sassessment of the effectiveness of its internal control over financial reporting under Section 404(b) of theSarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued itsaudit report. If securities are registered pursuant to Securities Act Section 12(b), indicate by check mark whether thefinancial statements of the registrant included in the filing reflect the correction of an error to previouslyissued financial statements. Indicate by check mark whether any of those error corrections are restatements that required a recoveryanalysis of incentive-based compensation received by any of the registrant’s executive officers during therelevant recovery period pursuant to §240.10D-1(b). Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the ExchangeAct). YesNo The aggregate market value of the common shares held by non-affiliates of the registrant as of the lastbusiness day of the registrant’s most recently completed second fiscal quarter was $2,125,737,497based onthe last reported sale price on the New York Stock Exchange on June 30, 2024. Thenumber of outstanding shares of the registrant’s common stock as of February 14,2025 was367,933,897. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference from the registrant’s proxy statement for the 2025Annual Meeting of Shareholders. Such proxy statement will be filed no later than 120 days after the close ofthe registrant’s fiscal year ended December 31, 2024. TABLE OF CONTENTS GENERAL INFORMATION PART I Item 1.Business1Item 1A.Risk Factors16Item 1B.Unresolved Staff Comments54Item 1C.Cybersecurity55Item 2.Properties56Item 3.Legal Proceedings57Item 4.Mine Safety Disclosures57PART IIItem 5.Market for Registrant’s Common Equity, Related Stockholder Mattersand Issuer Purchases of Equity Securities58Item 6.Reserved61Item 7.Management’s Discussion and Analysis of Financial Condition andResults of Operations62Item 7A.Quantitative and Qualitative Disclosures About Market Risk106Item 8.Financial Statements and Supplementary Data106Item 9.Changes in and Disagreements with Accountants on Accounting and106 Financial DisclosureItem 9A.Controls and Procedures106Item 9B.Other Information107Item9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections107 PART III Item 10.Directors, Executive Officers and Corporate Governance108Item 11